Application of nanotechnology in treatment of leishmaniasis: a review
Leishmaniasis is a neglected tropical disease caused by a protozoan species of the genus
Leishmania affecting mostly the develo** countries. The disease with current mortality rate …
Leishmania affecting mostly the develo** countries. The disease with current mortality rate …
Multi-targeting andrographolide and its natural analogs as potential therapeutic agents
Andrographis paniculata (A. paniculata) is a medicinal plant used in the Indian and Chinese
traditional medicinal systems for its various beneficial properties of therapeutics. This is due …
traditional medicinal systems for its various beneficial properties of therapeutics. This is due …
Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis
Visceral leishmaniasis, a protozoan disease transmitted by phlebotomine sandflies which
affect mostly in Indian sub-continent. The treatment for visceral leishmaniasis (VL) caused by …
affect mostly in Indian sub-continent. The treatment for visceral leishmaniasis (VL) caused by …
[HTML][HTML] Different susceptibilities of Leishmania spp. promastigotes to the Annona muricata acetogenins annonacinone and corossolone, and the Platymiscium …
NS Vila-Nova, SM de Morais, MJC Falcão… - Experimental …, 2013 - Elsevier
Leishmaniasis is a zoonotic disease that can manifest itself in visceral and cutaneous form.
The aim of this study was to search for new leishmanicidal compounds. Preliminarily …
The aim of this study was to search for new leishmanicidal compounds. Preliminarily …
Promising natural products for the treatment of cutaneous leishmaniasis: A review of in vitro and in vivo studies
RC Afonso, RMK Yien, LBO de Siqueira… - Experimental …, 2023 - Elsevier
Although there are available treatments for cutaneous leishmaniasis (CL), the drugs used
are far from ideal, toxic, and costly, in addition to the challenge faced by the development of …
are far from ideal, toxic, and costly, in addition to the challenge faced by the development of …
Evaluating the potential of ursolic acid as bioproduct for cutaneous and visceral leishmaniasis
Leishmaniasis affects around 12 million people worldwide and is estimated to cause the
ninth-largest disease burden. There are three main forms of the disease, visceral (VL) …
ninth-largest disease burden. There are three main forms of the disease, visceral (VL) …
Synthesis, characterization and antileishmanial activity of copper (II) and zinc (II) complexes with diamine ligands
CASR Condé, MV De Almeida, GS Da Silva… - Transition Metal …, 2022 - Springer
A new set of copper-and zinc-diamine (N-alkylated (L1) and N, N'-dialkylated (L2))
complexes,[Cu (L1) 2 (NO3) 2](1),[Cu (L1) 2 (Cl) 2]. 5H2O (2),[Cu (L2) 2 (NO3) 2](3),[Cu (L2) …
complexes,[Cu (L1) 2 (NO3) 2](1),[Cu (L1) 2 (Cl) 2]. 5H2O (2),[Cu (L2) 2 (NO3) 2](3),[Cu (L2) …
Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and …
C Khayeka–Wandabwa, HL Kutima, VCS Nyambati… - Parasites & vectors, 2013 - Springer
Background Most natural host populations are exposed to a diversity of parasite
communities and co-infection of hosts by multiple parasites is commonplace across a …
communities and co-infection of hosts by multiple parasites is commonplace across a …
Biosynthesis, characterization and leishmanicidal activity of a biocomposite containing AgNPs-PVP-glucantime
Aim: Development of functionalized nanocomposites containing AgNPs-PVP-Glucantime®
to evaluate their leishmanicidal activity as a novel method for improving the pharmacological …
to evaluate their leishmanicidal activity as a novel method for improving the pharmacological …
Formulation of oryzalin (ORZ) liposomes: in vitro studies and in vivo fate
Oryzalin (ORZ) is a dinitroaniline that has attracted increasing interest for the treatment of
leishmaniasis. The possible use of ORZ as an antiparasitic agent is limited by low water …
leishmaniasis. The possible use of ORZ as an antiparasitic agent is limited by low water …